首页 > 最新文献

International journal of oncology research最新文献

英文 中文
Usefulness of P16 and KI67 Immunostaining in Cervical Smear Cytology in Guatemalan Women: A Cross-Sectional Study P16和KI67免疫染色在危地马拉妇女宫颈涂片细胞学检查中的作用:一项横断面研究
Pub Date : 2019-10-18 DOI: 10.23937/2643-4563/1710019
G. Alberto, V. Angel, Quereda Francisco, O. Jaume, R. Orlando, Soch Erick, Morales H Arturo, Nave Federico, López-López Carlos
Background: Conventional cytology is an economic method for screening abnormalities in cervical smears, but with implications in false positive and false negative as compared to better detection of transformed cells with the Dual staining P16/KI67 proteins in cervical smears, therefore, we evaluate the validity and reproducibility of cytology with double staining of P16 and KI67 as compared to conventional cytology in cervical smears. Patients and methods: Participants were 210 Guatemalan women with abnormalities in conventional cytology (ASCUS, AGUS, ASCH, LSIL, HSIL, and cervical cancer) that consulted from 2013-2014 to the colposcopy Unit of Liga Nacional Contra El Cáncer e Instituto de Cancerología y Hospital Dr. Bernardo del Valle S. in Guatemala, from whom smear cytology was processed with P16 and KI67 immunostaining, and histological sections with P16 immunostaining as gold standard. They were evaluated by three blinded pathologists and one independent cytotechnologist. Results: The sensitivity and specificity of Dual staining P16/ KI67 for detecting abnormalities in cervical smears was 78.95%, 95% confidence interval (CI) 71.03-86.87 and 94.74%, 95%CI 89.06-100 respectively, as compare to conventional cytology in which it was 78.64% and 75.85%, respectively; positive predictive value (PPV) and negative predictive value (NPV) of Dual staining P16/KI67 were 95.74%, 95%CI 91.13-100.0 and 75%, 95%CI 65.82-84.18, as compare to conventional cytology in which it was 79.41% and 75% respectively. In women older than 30 years the sensitivity and PPV of Dual staining P16/KI67 was 78.43% and 95.24%, as compare in women less than 30 years in which it was 41.67% and 83.33% respectively. Interobserver agreement weighted Kappa indices for cervical smear cytology with double staining ranged between 0.66 to 0.83. Conclusion: Dual staining P16/KI67 in women older than 30 years showed better sensitivity and PPV values, suggesting greater utility in this age group, although the sensitivity was like conventional cytology, but with greater specificity and PPV.
背景:传统细胞学是筛查宫颈涂片异常的一种经济方法,但与在宫颈涂片中用P16/KI67双染色蛋白更好地检测转化细胞相比,有假阳性和假阴性的影响,因此,我们评估了P16和KI67双重染色的细胞学检查在宫颈涂片中与传统细胞学检查相比的有效性和可重复性。患者和方法:参与者是210名传统细胞学异常的危地马拉妇女(ASCUS、AGUS、ASCH、LSIL、HSIL和宫颈癌症),她们于2013-2014年咨询了危地马拉国家癌症研究所和医院Bernardo del Valle S.医生的阴道镜检查室,对其进行了P16和KI67免疫染色,以及P16免疫染色作为金标准的组织学切片。他们由三名失明的病理学家和一名独立的细胞技术专家进行评估。结果:P16/KI67双染色法检测宫颈涂片异常的敏感性和特异性分别为78.95%,95%可信区间(CI)为71.03-86.87和94.74%,95%CI为89.06-100,而常规细胞学检查的敏感性和特异度分别为78.64%和75.85%;双染色P16/KI67的阳性预测值(PPV)和阴性预测值(NPV)分别为95.74%,95%CI 91.13-100.0和75%,95%CI 65.82-84.18,而常规细胞学分别为79.41%和75%。P16/KI67双染色在30岁以上妇女中的敏感性和PPV分别为78.43%和95.24%,而在30岁以下妇女中的灵敏度和PPV则分别为41.67%和83.33%。双染色宫颈涂片细胞学的观察者间一致性加权Kappa指数在0.66至0.83之间。结论:P16/KI67双染色在30岁以上女性中显示出更好的敏感性和PPV值,表明在该年龄组中有更大的实用性,尽管敏感性与传统细胞学相似,但具有更高的特异性和PPV。
{"title":"Usefulness of P16 and KI67 Immunostaining in Cervical Smear Cytology in Guatemalan Women: A Cross-Sectional Study","authors":"G. Alberto, V. Angel, Quereda Francisco, O. Jaume, R. Orlando, Soch Erick, Morales H Arturo, Nave Federico, López-López Carlos","doi":"10.23937/2643-4563/1710019","DOIUrl":"https://doi.org/10.23937/2643-4563/1710019","url":null,"abstract":"Background: Conventional cytology is an economic method for screening abnormalities in cervical smears, but with implications in false positive and false negative as compared to better detection of transformed cells with the Dual staining P16/KI67 proteins in cervical smears, therefore, we evaluate the validity and reproducibility of cytology with double staining of P16 and KI67 as compared to conventional cytology in cervical smears. Patients and methods: Participants were 210 Guatemalan women with abnormalities in conventional cytology (ASCUS, AGUS, ASCH, LSIL, HSIL, and cervical cancer) that consulted from 2013-2014 to the colposcopy Unit of Liga Nacional Contra El Cáncer e Instituto de Cancerología y Hospital Dr. Bernardo del Valle S. in Guatemala, from whom smear cytology was processed with P16 and KI67 immunostaining, and histological sections with P16 immunostaining as gold standard. They were evaluated by three blinded pathologists and one independent cytotechnologist. Results: The sensitivity and specificity of Dual staining P16/ KI67 for detecting abnormalities in cervical smears was 78.95%, 95% confidence interval (CI) 71.03-86.87 and 94.74%, 95%CI 89.06-100 respectively, as compare to conventional cytology in which it was 78.64% and 75.85%, respectively; positive predictive value (PPV) and negative predictive value (NPV) of Dual staining P16/KI67 were 95.74%, 95%CI 91.13-100.0 and 75%, 95%CI 65.82-84.18, as compare to conventional cytology in which it was 79.41% and 75% respectively. In women older than 30 years the sensitivity and PPV of Dual staining P16/KI67 was 78.43% and 95.24%, as compare in women less than 30 years in which it was 41.67% and 83.33% respectively. Interobserver agreement weighted Kappa indices for cervical smear cytology with double staining ranged between 0.66 to 0.83. Conclusion: Dual staining P16/KI67 in women older than 30 years showed better sensitivity and PPV values, suggesting greater utility in this age group, although the sensitivity was like conventional cytology, but with greater specificity and PPV.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48787303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer 癌症犬类嗜神经病毒疫苗(CIMT-54)的免疫治疗
Pub Date : 2019-10-16 DOI: 10.23937/2643-4563/1710018
Puello Hugo Ramiro Segurab, Charry Juan Sebastián Segura, Muñoz-Forero Diana Milena, Mosquera Diana Lorena Nieto, Villamil-Ballesteros Andrea Catalina
• Page 1 of 8 • Citation: Segura-Puello HR, Charry JSS, Muñoz-Forero DM, Mosquera DJN, Villamil-Ballesteros AC (2019) Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer. Int J Oncol Res 2:018. doi.org/10.23937/2643-4563/1710018 Accepted: October 14, 2019; Published: October 16, 2019 Copyright: © 2019 Segura-Puello HR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
•第1页,共8页•引用:Segura-Puello HR,Charry JSS,Muñoz-Forero DM,Mosquera DJN,Villamil-Ballesteros AC(2019)基于犬类嗜神经病毒疫苗的免疫疗法(CIMT-54)用于治疗癌症。Int J Oncol Res 2:018。doi.org/10.23937/2643-4563/171018接受日期:2019年10月14日;发布时间:2019年10月16日版权所有:©2019 Segura Puello HR等人。这是一篇根据知识共享署名许可证条款分发的开放获取文章,该许可证允许在任何媒体上不受限制地使用、分发和复制,前提是原作者和来源可信。
{"title":"Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer","authors":"Puello Hugo Ramiro Segurab, Charry Juan Sebastián Segura, Muñoz-Forero Diana Milena, Mosquera Diana Lorena Nieto, Villamil-Ballesteros Andrea Catalina","doi":"10.23937/2643-4563/1710018","DOIUrl":"https://doi.org/10.23937/2643-4563/1710018","url":null,"abstract":"• Page 1 of 8 • Citation: Segura-Puello HR, Charry JSS, Muñoz-Forero DM, Mosquera DJN, Villamil-Ballesteros AC (2019) Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer. Int J Oncol Res 2:018. doi.org/10.23937/2643-4563/1710018 Accepted: October 14, 2019; Published: October 16, 2019 Copyright: © 2019 Segura-Puello HR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44691623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacokinetics of Oxaliplatin in a Hemodialysis Patient with Metastatic Colon Cancer 奥沙利铂在癌症转移性血液透析患者中的药代动力学
Pub Date : 2019-09-16 DOI: 10.23937/2643-4563/1710017
N. Yoshiaki, I. Yoshinori, N. Tsutomu, Yamashita Kazuhiko, Okuno Mamoru, Yasui Hiroyuki, Hiraoka Jun, Niigata Riho, Kono Keiji, Hyogo Yasuko, S. Hirotaka, Takenaka Kei, Funakoshi Yohei, Toyoda Masanori, K. Naomi, Minami Hironobu
• Page 1 of 5 • Citation: Nagatani Y, Imamura Y, Nakamura T, Yamashita K, Okuno M, et al. (2019) Pharmacokinetics of Oxaliplatin in a Hemodialysis Patient with Metastatic Colon Cancer. Int J Oncol Res 2:017. doi. org/10.23937/2643-4563/1710017 Accepted: September 14, 2019; Published: September 16, 2019 Copyright: © 2019 Nagatani Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
•引文:Nagatani Y, Imamura Y, Nakamura T, Yamashita K, Okuno M等。(2019)奥沙利铂在血液透析患者转移性结肠癌中的药代动力学。《国际医学杂志》2:17。doi。录用日期:2019年9月14日;出版日期:2019年9月16日版权所有:©2019 Nagatani Y, et al。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是要注明原作者和来源。
{"title":"Pharmacokinetics of Oxaliplatin in a Hemodialysis Patient with Metastatic Colon Cancer","authors":"N. Yoshiaki, I. Yoshinori, N. Tsutomu, Yamashita Kazuhiko, Okuno Mamoru, Yasui Hiroyuki, Hiraoka Jun, Niigata Riho, Kono Keiji, Hyogo Yasuko, S. Hirotaka, Takenaka Kei, Funakoshi Yohei, Toyoda Masanori, K. Naomi, Minami Hironobu","doi":"10.23937/2643-4563/1710017","DOIUrl":"https://doi.org/10.23937/2643-4563/1710017","url":null,"abstract":"• Page 1 of 5 • Citation: Nagatani Y, Imamura Y, Nakamura T, Yamashita K, Okuno M, et al. (2019) Pharmacokinetics of Oxaliplatin in a Hemodialysis Patient with Metastatic Colon Cancer. Int J Oncol Res 2:017. doi. org/10.23937/2643-4563/1710017 Accepted: September 14, 2019; Published: September 16, 2019 Copyright: © 2019 Nagatani Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42232634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Nimotuzumab in Advanced Cervical Cancer: Safety and Efficacy Profile 尼莫单抗在晚期宫颈癌中的安全性和有效性
Pub Date : 2019-07-29 DOI: 10.23937/2643-4563/1710016
Lorente Raiza Ruiz, Alfonso Sayly, Sanchez Yamilka, Viada Carmen Elena, O. Ramón, Troche Mayelin, C. Meylan, Vals Ana Rosa, Cabrera Leticia, Gorte Annia, Batista Delmis Maira, D. Milagros, Viamontes Jessica Garcia, Mico Conrado Ramos, Suzarte Mayra Ramos
• Page 1 of 8 • Citation: Lorente RR, Alfonso S, Sanchez Y, Viada C, Ortiz R, Ortiz CEVR, Troche M, et al. (2019) Nimotuzumab in Advanced Cervical Cancer: Safety and Efficacy Profile. Int J Oncol Res 2:016. doi. org/10.23937/2643-4563/1710016 Accepted: July 27, 2019; Published: July 29, 2019 Copyright: © 2019 Lorente RR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
•引用本文:Lorente RR, Alfonso S, Sanchez Y, Viada C, Ortiz R, Ortiz CEVR, Troche M等。(2019)尼妥珠单抗在晚期宫颈癌中的安全性和有效性分析。《国际医学杂志》2:16。doi。录用日期:2019年7月27日;出版日期:2019年7月29日版权所有:©2019 Lorente RR, et al。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是要注明原作者和来源。
{"title":"Nimotuzumab in Advanced Cervical Cancer: Safety and Efficacy Profile","authors":"Lorente Raiza Ruiz, Alfonso Sayly, Sanchez Yamilka, Viada Carmen Elena, O. Ramón, Troche Mayelin, C. Meylan, Vals Ana Rosa, Cabrera Leticia, Gorte Annia, Batista Delmis Maira, D. Milagros, Viamontes Jessica Garcia, Mico Conrado Ramos, Suzarte Mayra Ramos","doi":"10.23937/2643-4563/1710016","DOIUrl":"https://doi.org/10.23937/2643-4563/1710016","url":null,"abstract":"• Page 1 of 8 • Citation: Lorente RR, Alfonso S, Sanchez Y, Viada C, Ortiz R, Ortiz CEVR, Troche M, et al. (2019) Nimotuzumab in Advanced Cervical Cancer: Safety and Efficacy Profile. Int J Oncol Res 2:016. doi. org/10.23937/2643-4563/1710016 Accepted: July 27, 2019; Published: July 29, 2019 Copyright: © 2019 Lorente RR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47079940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Atypical Presentation of Denny-Brown Syndrome: A Case Report and Review of Literature Denny Brown综合征的非典型表现:一例报告及文献复习
Pub Date : 2019-06-01 DOI: 10.23937/2643-4563/1710014
Romeo V. Porlas, S. K. Ong, G. Saranza, J. P. Reyes
{"title":"Atypical Presentation of Denny-Brown Syndrome: A Case Report and Review of Literature","authors":"Romeo V. Porlas, S. K. Ong, G. Saranza, J. P. Reyes","doi":"10.23937/2643-4563/1710014","DOIUrl":"https://doi.org/10.23937/2643-4563/1710014","url":null,"abstract":"","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47424691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydropneumopericardium: Unusual Complication of Proton Radiotherapy 心包积液:质子放疗的罕见并发症
Pub Date : 2019-05-13 DOI: 10.23937/2643-4563/1710012
Yasuhiro Nakamura
{"title":"Hydropneumopericardium: Unusual Complication of Proton Radiotherapy","authors":"Yasuhiro Nakamura","doi":"10.23937/2643-4563/1710012","DOIUrl":"https://doi.org/10.23937/2643-4563/1710012","url":null,"abstract":"","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47357759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostatic Ductal Adenocarcinoma: An Unusual Subtype of Prostate Cancer 前列腺导管腺癌:一种罕见的前列腺癌亚型
Pub Date : 2019-01-01 DOI: 10.23937/2643-4563/1710013
D. Kumar, J. Lobo
• Page 1 of 2 • Citation: Kumar D, Lobo J (2019) Prostatic Ductal Adenocarcinoma: An Unusual Subtype of Prostate Cancer. Int J Oncol Res 2:013 Accepted: May 23, 2019; Published: May 25, 2019 Copyright: © 2019 Kumar D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
•引用本文:Kumar D, Lobo J(2019)前列腺导管腺癌:一种罕见的前列腺癌亚型。国际医学杂志,2019年5月23日;出版日期:2019年5月25日版权所有:©2019 Kumar D, et al。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是要注明原作者和来源。
{"title":"Prostatic Ductal Adenocarcinoma: An Unusual Subtype of Prostate Cancer","authors":"D. Kumar, J. Lobo","doi":"10.23937/2643-4563/1710013","DOIUrl":"https://doi.org/10.23937/2643-4563/1710013","url":null,"abstract":"• Page 1 of 2 • Citation: Kumar D, Lobo J (2019) Prostatic Ductal Adenocarcinoma: An Unusual Subtype of Prostate Cancer. Int J Oncol Res 2:013 Accepted: May 23, 2019; Published: May 25, 2019 Copyright: © 2019 Kumar D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68754682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Specific Music on Psychoneuroimmunological Responses 特定音乐对心理神经免疫反应的影响
Pub Date : 2018-12-31 DOI: 10.23937/ijor-2017/1710011
Waheed Abdul, K. David, C. William, C. Amy
• Page 1 of 16 • Citation: Waheed A, Kossor D, Collins W, Camie A (2018) Effect of Specific Music on Psychoneuroimmunological Responses. Int J Oncol Res 1:011. Accepted: December 29, 2018; Published: December 31, 2018 Copyright: © 2018 Waheed A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
•引文:Waheed A, Kossor D, Collins W, Camie A(2018)特定音乐对心理神经免疫反应的影响。《中华医学会杂志》1:11。录用日期:2018年12月29日;出版日期:2018年12月31日版权所有:©2018 Waheed A, et al。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是要注明原作者和来源。
{"title":"Effect of Specific Music on Psychoneuroimmunological Responses","authors":"Waheed Abdul, K. David, C. William, C. Amy","doi":"10.23937/ijor-2017/1710011","DOIUrl":"https://doi.org/10.23937/ijor-2017/1710011","url":null,"abstract":"• Page 1 of 16 • Citation: Waheed A, Kossor D, Collins W, Camie A (2018) Effect of Specific Music on Psychoneuroimmunological Responses. Int J Oncol Res 1:011. Accepted: December 29, 2018; Published: December 31, 2018 Copyright: © 2018 Waheed A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68755148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Economic Costs of Lung Cancer in China 中国癌症的经济成本
Pub Date : 2018-12-31 DOI: 10.23937/IJOR-2017/1710007
Fan Shaoyu, M. Zhengzhong, H LeeAnita, Hu Teh-wei
• Page 1 of 5 • Citation: Fan S, Mao Z, Lee AH, Teh-wei H (2018) Economic Costs of Lung Cancer in China. Int J Oncol Res 1:007. Accepted: September 27, 2018; Published: September 29, 2018 Copyright: © 2018 Fan S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
•第1页,共5页•引文:Fan S,Mao Z,Lee AH,Teh-wei H(2018)中国癌症的经济成本。Int J Oncol Res 1:007。验收日期:2018年9月27日;发布时间:2018年9月29日版权所有:©2018 Fan S等人。这是一篇根据知识共享署名许可证条款分发的开放获取文章,该许可证允许在任何媒体上不受限制地使用、分发和复制,前提是原作者和来源可信。
{"title":"Economic Costs of Lung Cancer in China","authors":"Fan Shaoyu, M. Zhengzhong, H LeeAnita, Hu Teh-wei","doi":"10.23937/IJOR-2017/1710007","DOIUrl":"https://doi.org/10.23937/IJOR-2017/1710007","url":null,"abstract":"• Page 1 of 5 • Citation: Fan S, Mao Z, Lee AH, Teh-wei H (2018) Economic Costs of Lung Cancer in China. Int J Oncol Res 1:007. Accepted: September 27, 2018; Published: September 29, 2018 Copyright: © 2018 Fan S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41367150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Organoids as Reliable Breast Cancer Study Models: An Update 类器官作为可靠的乳腺癌研究模型:最新进展
Pub Date : 2018-12-31 DOI: 10.23937/ijor-2017/1710008
Sasmita Andrew Octavian, Wong Ying Pei
{"title":"Organoids as Reliable Breast Cancer Study Models: An Update","authors":"Sasmita Andrew Octavian, Wong Ying Pei","doi":"10.23937/ijor-2017/1710008","DOIUrl":"https://doi.org/10.23937/ijor-2017/1710008","url":null,"abstract":"","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68755136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
International journal of oncology research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1